LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?

about

LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?

Item

http://www.wikidata.org/entity/Q41855417

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

LINGO-1 and AMIGO3, potential ...... and dysmyelinating disorders?

@en

type

Item

label

LINGO-1 and AMIGO3, potential ...... and dysmyelinating disorders?

@en

prefLabel

LINGO-1 and AMIGO3, potential ...... and dysmyelinating disorders?

@en

P1476

LINGO-1 and AMIGO3, potential ...... and dysmyelinating disorders?

@en

P2093

Ann Logan

http://www.w3.org/2001/XMLSchema#string

Daniel Fulton

http://www.w3.org/2001/XMLSchema#string

Martin Berry

http://www.w3.org/2001/XMLSchema#string

Simon Foale

http://www.w3.org/2001/XMLSchema#string

P2860

AMIGO, a transmembrane protein implicated in axon tract development, defines a novel protein family with leucine-rich repeats

Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models

LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.

Modulation of Oligodendrocyte Differentiation by Mechanotransduction

LINGO-1 negatively regulates myelination by oligodendrocytes

LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions.

Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic.

Axon growth inhibition by RhoA/ROCK in the central nervous system.

TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions.

AMIGO3 is an NgR1/p75 co-receptor signalling axon growth inhibition in the acute phase of adult central nervous system injury.

P304

1247-1251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1673-5374.213538

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zubair Ahmed

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28966634

http://www.w3.org/2001/XMLSchema#string

P932

5607814

http://www.w3.org/2001/XMLSchema#string